Abstract:Pathological tau aggregates occur in Alzheimer's disease (AD) and other neurodegenerative tauopathies. It is not clearly understood why tauopathies vary greatly in the neuroanatomical and histopathological patterns of tau aggregation, which contribute to clinical heterogeneity in these disorders. Recent studies have shown that tau aggregates may form distinct structural conformations, known as tau strains. Here, we developed a novel model to test the hypothesis that cell-to-cell transmission of different tau strains occurs in nontransgenic (non-Tg) mice, and to investigate whether there are strain-specific differences in the pattern of tau transmission. By injecting pathological tau extracted from postmortem brains of AD (AD-tau), progressive supranuclear palsy (PSP-tau), and corticobasal degeneration (CBD-tau) patients into different brain regions of female non-Tg mice, we demonstrated the induction and propagation of endogenous mouse tau aggregates. Specifically, we identified differences in tau strain potency between AD-tau, CBD-tau, and PSP-tau in non-Tg mice. Moreover, differences in cell-type specificity of tau aggregate transmission were observed between tau strains such that only PSP-tau and CBD-tau strains induce astroglial and oligodendroglial tau inclusions, recapitulating the diversity of neuropathology in human tauopathies. Furthermore, we demonstrated that the neuronal connectome, but not the tau strain, determines which brain regions develop tau pathology. Finally, CBD-tau- and PSP-tau-injected mice showed spatiotemporal transmission of glial tau pathology, suggesting glial tau transmission contributes to the progression of tauopathies. Together, our data suggest that different tau strains determine seeding potency and cell-type specificity of tau aggregation that underlie the diversity of human tauopathies.SIGNIFICANCE STATEMENTTauopathies show great clinical and neuropathological heterogeneity, despite the fact that tau aggregates in each disease. This heterogeneity could be due to tau aggregates forming distinct structural conformations, or strains. We now report the development of a sporadic tauopathy model to study human tau strains by intracerebrally injecting nontransgenic mice with pathological tau enriched from human tauopathy brains. We show human tau strains seed different types and cellular distributions of tau neuropathology in our model that recapitulate the heterogeneity seen in these human diseases.

In Vitro Amplification of Pathogenic Tau Seeds from Neurodegenerative Disease Patient Brains

In Vitro Amplification of Pathogenic Tau Conserves Disease-Specific Bioactive Characteristics

Modeling Tauopathy Using Human-Like Pathogenic Tau Seeds.

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

A seeding based cellular assay of tauopathy

Sensitive detection and propagation of brain-derived tau assemblies in HEK293 based wild-type tau seeding assays

Unique Pathological Tau Conformers from Alzheimer'S Brains Transmit Tau Pathology in Nontransgenic Mice

Tau seeding without tauopathy

Trans‐seeding of Alzheimer‐related tau protein by a yeast prion

Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles*

O3‐01‐05: in vitro measurements of tau aggregate elongation and fragmentation rates allow the modelling of prion‐like spreading in humans

Protocol for the isolation and proteomic analysis of pathological tau-seeds

Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization

Neurofibrillary Tangle-Like Tau Pathology Induced by Synthetic Tau Fibrils in Primary Neurons Over-Expressing Mutant Tau.

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models

Gfp-Mutant Human Tau Transgenic Mice Develop Tauopathy Following Cns Injections Of Alzheimer'S Brain-Derived Pathological Tau Or Synthetic Mutant Human Tau Fibrils

Polymerization of recombinant tau core fragments in vitro and seeding studies in cultured cells

Correction To: Anatomic Survey of Seeding in Alzheimer's Disease Brains Reveals Unexpected Patterns.

A brain‐seeded fibril amplification models the aggregation process of tau in Alzheimer’s disease for drug discovery

In situ seeding assay: A novel technique for direct tissue localization of bioactive tau

Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain